Novartis Investor RelationsCentral investor relations line: +41 61 324 7944E-mail: [email protected] | |||
Central |
North America |
||
Samir Shah |
+41 61 324 7944 |
Richard Pulik |
+1 212 830 2448 |
Pierre-Michel Bringer |
+41 61 324 1065 |
Cory Twining |
+1 212 830 2417 |
Thomas Hungerbuehler |
+41 61 324 8425 |
||
Isabella Zinck |
+41 61 324 7188 |